{"id":"NCT00790023","sponsor":"Sumitomo Pharma America, Inc.","briefTitle":"Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis","officialTitle":"A Randomized, Multicenter, Double Blind, Placebo Controlled, Parallel Group, Phase III Clinical Trial to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol (160 μg Once Daily and 80 μg Once Daily) for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-11","primaryCompletion":"2009-02","completion":"2009-02","firstPosted":"2008-11-13","resultsPosted":"2012-06-08","lastUpdate":"2016-04-08"},"enrollment":707,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Seasonal Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"80 mcg Ciclesonide","otherNames":[]},{"type":"DRUG","name":"160 mcg Ciclesonide","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"80 mcg Ciclesonide","type":"EXPERIMENTAL"},{"label":"160 mcg Ciclesonide","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To demonstrate the efficacy of ciclesonide HFA applied as a nasal aerosol (160 μg and 80 μg) once daily compared to placebo in subjects with SAR.","primaryOutcome":{"measure":"Change From Baseline in Daily Subject-reported AM and PM Reflective Total Nasal Symptom Score (rTNSS) Averaged Over the Two-week Treatment Period.","timeFrame":"Week 0-2","effectByArm":[{"arm":"80 mcg Ciclesonide","deltaMin":-1.45,"sd":0.14},{"arm":"160 mcg Ciclesonide","deltaMin":-1.59,"sd":0.14},{"arm":"Placebo","deltaMin":-0.51,"sd":0.14}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":21},"locations":{"siteCount":4,"countries":["United States"]},"refs":{"pmids":["21130386"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":237},"commonTop":["Epistaxis","Nasal discomort","Instillation site irritation","Nasal septum disorder"]}}